Wexner Medical Center among first in nation to administer new gene therapy for ALS
Ohio State University Wexner Medical CenterThe Ohio State University Wexner Medical Center is one of the first nationwide to administer a targeted gene therapy for patients with a specific form of amyotrophic lateral sclerosis (ALS), a neurodegenerative disease that affects the cells in the brain and spine.